• Value Research Rating market-capitalisation-info
    4 star
  • Market Capitalisation market-capitalisation-info ₹3,390 Cr
  • Price to Earnings Ratio price-to-earning 57.29
  • 12 Month Earnings monthly-earning ₹59 Cr
Value Research Rating
4 star
Quality Score fund-quick-summary-circle
10/10
Growth Score fund-quick-summary-circle
5/10
Valuation Score fund-quick-summary-circle
3/10

Gujarat Themis Biosyn Ltd. Share Price

₹466.60

As on 19-Jul-2024 IST

up-down-arrow-13.30-2.77%

  • Prev Close info

    479.90

  • Day's Openinfo

    474.10

  • Today's Highinfo

    482.00

  • Today's Lowinfo

    455.00

  • Today's Volumeinfo

    43,808

  • 52 Week rangeinfo

    ₹152.22 - 530.00

Please wait...

Stock Range

Today’s Range
Low 455.00 High: 482.00
52 Week Range
Low 152.22 High: 530.00
Liquidity
Low High

Gujarat Themis Biosyn Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Gujarat Themis
81.87 -2.90 21.81 195.20 82.11 126.43 61.23
BSE Healthcare
20.94 2.76 10.36 44.85 13.20 24.02 12.42
BSE Small Cap
22.98 1.52 15.47 55.14 25.64 31.09 17.82
As on 19-Jul-2024
2023
2022
2021
2020
2019
2018
2017
Gujarat Themis
65.76 62.30 88.87 326.87 79.39 -47.86 19.96
BSE Small Cap
47.52 -1.80 62.77 32.11 -6.85 -23.41 59.64
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Gujarat Themis Biosyn Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Gujarat Themis Biosyn Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Gujarat Themis Biosyn Ltd.

        Other details of Gujarat Themis Biosyn Ltd.

        Incorporated

        1981

        Chairman

        Dinesh S Patel

        Managing Director

        --

        Headquarters

        Valsad Dist, Gujarat

        Website

        www.gtbl.in

        FAQs for Gujarat Themis Biosyn Ltd.

        The total asset value of Gujarat Themis Biosyn Ltd stood at ₹ 241 Cr as on 31-Mar-24

        The share price of Gujarat Themis Biosyn Ltd is ₹466.60 (BSE) and ₹7.30 (NSE) as of 19-Jul-2024 IST. Gujarat Themis Biosyn Ltd has given a return of 82.11% in the last 3 years.

        Gujarat Themis Biosyn Ltd has a market capitalisation of ₹ 3,390 Cr as on 19-Jul-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Gujarat Themis Biosyn Ltd is 16.83 times as on 19-Jul-2024, a 308% premium to its peers’ median range of 4.12 times.

        The P/E ratio of Gujarat Themis Biosyn Ltd is 57.29 times as on 19-Jul-2024, a 21% premium to its peers’ median range of 47.18 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Gujarat Themis Biosyn Ltd and enter the required number of quantities and click on buy to purchase the shares of Gujarat Themis Biosyn Ltd.

        Gujarat Themis Biosyn Limited manufactures and sells bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; and Lovastatin. Gujarat Themis Biosyn Limited was incorporated in 1981 and is based in Vapi, India.

        The promoters of Gujarat Themis Biosyn Ltd are Pharmaceutical Business Group (India) Ltd and Themis Medicare Limited. They collectively own 70.21 per cent of the total equity. The chairman of the company is Dinesh S Patel

        The promoters of Gujarat Themis Biosyn Ltd have pledged 2.34% of the total equity as on Jun-24.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        10,424
        10,375
        6,586
        4,712
        Gujarat Themis Biosyn Ltd. Ratios
        Return on equity(%)
        33.76
        Operating margin(%)
        44.28
        Net Margin(%)
        33.97
        Dividend yield(%)
        0.25

        Yes, TTM profit after tax of Gujarat Themis Biosyn Ltd was ₹59 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹3,389.55 Cr
        • Revenue (TTM)revenue-information ₹169.82 Cr
        • Earnings (TTM) earning-information ₹59.16 Cr
        • Cash date-information ₹8.16 Cr
        • Total Debt info ₹0.00 Cr
        • Promoters' ownership promoters_ownership 70.86%
        • Liquidity liquidity High
        • 52 Week range week-range ₹152.22 - 530.00
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 7,26,43,510
        • 10 Years Aggregate:

          CFO: ₹170.86 Cr

          EBITDA: ₹314.53 Cr

          Net Profit: ₹238.49 Cr

        About The Company

        • Incorporated 1981
        • Chairman Dinesh S Patel
        • Managing Director --
        • Listing key-listing NSE: GUJTHEMIS, BSE: 506879
        • Country India
        • Headquarters headquarters Valsad Dist, Gujarat
        • Website website www.gtbl.in
        • Business

          Gujarat Themis Biosyn Limited manufactures and sells bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; and Lovastatin. Gujarat Themis Biosyn Limited was incorporated in 1981...  and is based in Vapi, India.  Read more